Biogen Inc (BIIB)
221.41
+3.90
(+1.79%)
USD |
NASDAQ |
May 06, 16:00
224.00
+2.59
(+1.17%)
After-Hours: 04:39
Biogen 1 Year Total Returns (Daily): -30.39% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 06, 2024 | -30.39% |
May 03, 2024 | -30.06% |
May 02, 2024 | -30.97% |
May 01, 2024 | -30.53% |
April 30, 2024 | -29.39% |
April 29, 2024 | -29.17% |
April 26, 2024 | -27.48% |
April 25, 2024 | -28.31% |
April 24, 2024 | -31.07% |
April 23, 2024 | -34.29% |
April 22, 2024 | -33.97% |
April 19, 2024 | -33.49% |
April 18, 2024 | -35.16% |
April 17, 2024 | -34.24% |
April 16, 2024 | -32.27% |
April 15, 2024 | -31.70% |
April 12, 2024 | -30.66% |
April 11, 2024 | -28.20% |
April 10, 2024 | -28.75% |
April 09, 2024 | -27.99% |
April 08, 2024 | -28.54% |
April 05, 2024 | -28.21% |
April 04, 2024 | -25.41% |
April 03, 2024 | -25.59% |
April 02, 2024 | -25.32% |
Date | Value |
---|---|
April 01, 2024 | -22.73% |
March 28, 2024 | -20.21% |
March 27, 2024 | -19.87% |
March 26, 2024 | -21.48% |
March 25, 2024 | -19.75% |
March 22, 2024 | -16.51% |
March 21, 2024 | -17.06% |
March 20, 2024 | -18.57% |
March 19, 2024 | -16.92% |
March 18, 2024 | -16.63% |
March 15, 2024 | -16.41% |
March 14, 2024 | -16.29% |
March 13, 2024 | -12.37% |
March 12, 2024 | -11.38% |
March 11, 2024 | -10.33% |
March 08, 2024 | -15.12% |
March 07, 2024 | -17.19% |
March 06, 2024 | -19.50% |
March 05, 2024 | -19.62% |
March 04, 2024 | -18.22% |
March 01, 2024 | -18.83% |
February 29, 2024 | -19.59% |
February 28, 2024 | -17.83% |
February 27, 2024 | -16.81% |
February 26, 2024 | -17.15% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-52.38%
Minimum
Jun 10 2022
67.43%
Maximum
May 09 2023
-0.97%
Average
-5.98%
Median
Feb 28 2020
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 80.70% |
Bristol-Myers Squibb Co | -32.81% |
Gilead Sciences Inc | -14.56% |
AbbVie Inc | 14.41% |
Sage Therapeutics Inc | -72.97% |